|
Investors Reaction to Genentech News, CNNfn.
Publication: Finance Wire Publication Date: 26-NOV-03 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2003 FDCH e-media
Original Source: STREET SWEEP
results from its trial on the cancer drug of Avaston (ph). Our stocks editor Chris Huntington tells us how investors are reacting to that news. Hi Chris.
CHRIS HUNTINGTON, CNNfn STOCKS EDITOR: Christine, thanks. Well, investors right now are not reacting all that favorably to the news that Genentech`s star cancer treating drug Avaston for treating colon rectal cancer, did not significantly extend the lives of the patients in a clinical trial. And the key words there are a significantly extend. Because while it did show some helpful, efficacy in fighting the disease it did not apparently achieve the upper level of expectations. So, Genentech` still hopeful that the drug will be approved by the Food and Drug Administration, but not apparently on track to hit...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from Finance Wire |
Bond Market Perspective On Stick Shock Congress, CNNfn.
November 26, 2003
|
Giving Coins As An Investment, CNNfn.
November 26, 2003
|
Are You Ready For Macy`s Thanksgiving Day Parade?, CNNfn.
November 26, 2003
|
Economic Analysis: Durable Goods Orders, Jobless Claims, CNNfn.
November 26, 2003
|
Economic Outlook, CNNfn.
November 26, 2003
|
|
| Find companies classified under Accounting auditing bookkeeping |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
